Big change for #SLE Trials coming soon. My exclusive interview w/Prof @EricFMorand. Future trials will likely incorporate this Novel Treatment Response Measurement (TRM) Tool #ACR22 @rheumnow https://t.co/TXsxJi3qhC

Our work presented at #ACR22 showing increased mast cells and tryptase activity in women with OA compared to men! Food for thought - can simple allergy meds help in OA management? @RheumNow abst#1642. https://t.co/cBQZU5MXeR

Cancer risk with tofacitinib vs TNFi in RA: we learned at #ACR21 that CV-enriched pts: risk (ORAL Surveillance) all comers: no risk (STAR-RA) French national healthcare database #ACR22 looks at all comers: nothing to separate tofa and TNFi. Risk begets risk ABST1984 @RheumNow https://t.co/0GG04NSP3D https://t.co/nwQz7fx21M

Based on your experience, will you attend #ACR23 next year ... @ACRheum @rheumnow

⚡️Pulmonary pulse wave transit time⚡️ 👉novel non-invasive echo measure of ⬆️pulm vasc tone in pulm HTN 👉hyperuricaemic pts ⬇️pPTT sugg of pulm vasc dysfn @FloodRachael #ACR22 Abst1788 @RheumNow https://t.co/ZEORWbqw6f

Still for me the most interesting bit from the GLORIA study (PNL 5 add-on in RA) is the coming off of it. Patients were able to come off their long-term low-dose prednisolone. No Sx/biochem differences vs placebo. True #squadgoals for rheumatologists ABST2000 #ACR22 @RheumNow https://t.co/eQLcgqA1SN https://t.co/RGTCrMhld7

Cumulative dose and exposure to methotrexate were not predictors of hepatic fibrosis. Hepatic fibrosis as measured by elastography associated with daily EtOH use. #ACRBest Abs#2147 @RheumNow #ACR22

Peritonitis of the #FMF - misdiagnosed as acute abdomen Acute appendicitis is the leading cause of acute abdomen in FMF Turkish study 1655 #FMF pts 15.8% appendectomy rates! CRP ineffective for differing FMF from appendicitis :( @RheumNow #ACR22 abst#1839

Factors associated with non-achievement of MDA in PsA pts receiving golimumab: Baseline tender joint count, fibromyalgia, older age, smoking, high BMI Abs#2109 @RheumNow #ACR22 https://t.co/dEzQxVtavh

‼️‼️Frailty ‼️‼️ 👉Important predictor of serious infxn in RA pts on b- or tsDMARD irrespective of age ‼️‼️ @NamrataRheum illustrating yet another reason why it is so NB to evaluate 4 frailty in ALL (incl young) pts with RA #GeriRheum Abst2218 @RheumNow #ACR22 https://t.co/J4XQFmVoUw